Showing results (461-470 of 660) with videos related to

Sort By:
Pageof 66
Clinical Trials (London, England)|May 21, 2025
Concordance between clinical trial data use request proposals and corresponding publications: A cross-sectional studyEnrique Vazquez, Joseph S Ross, Cary P Gross, et al.
Systematic Reviews|February 16, 2017
Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic ProjectJeffrey Low, Joseph S Ross, Jessica D Ritchie, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized controlled trialsEvangelos K Oikonomou, Phyllis M Thangaraj, Deepak L Bhatt, et al.
Health Affairs (Project Hope)|January 11, 2012
State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warningJoseph S Ross, Cynthia Jackevicius, Harlan M Krumholz, et al.
Medical Care|April 5, 2008
Dual use of Veterans Affairs services and use of recommended ambulatory careJoseph S Ross, Salomeh Keyhani, Patricia S Keenan, et al.
JAMA Internal Medicine|June 30, 2025
FDA Authorization of Therapeutic Devices Under the Breakthrough Devices ProgramKushal T Kadakia, Sanket S Dhruva, Joseph S Ross, et al.
JCO Oncology Practice|June 10, 2025
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over TimeJennifer E Miller, William Pelletiers, Cary P Gross, et al.
Annals of Internal Medicine|May 3, 2016
Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort StudyIsuru Ranasinghe, Craig S Parzynski, James V Freeman, et al.
NPJ Digital Medicine|November 24, 2023
An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trialsEvangelos K Oikonomou, Phyllis M Thangaraj, Deepak L Bhatt, et al.
JAMA Network Open|May 5, 2021
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved DrugsJennifer E Miller, Michelle M Mello, Joshua D Wallach, et al.
Pageof 66